➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Dow
Express Scripts
Mallinckrodt
Johnson and Johnson

Last Updated: July 8, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 011525


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 011525 describes IC-GREEN, which is a drug marketed by Akorn and is included in one NDA. It is available from one supplier. Additional details are available on the IC-GREEN profile page.

The generic ingredient in IC-GREEN is indocyanine green. There are three drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the indocyanine green profile page.
Summary for 011525
Tradename:IC-GREEN
Applicant:Akorn
Ingredient:indocyanine green
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 011525
Suppliers and Packaging for NDA: 011525
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
IC-GREEN indocyanine green INJECTABLE;INJECTION 011525 NDA Akorn, Inc. 17478-701 17478-701-02 1 KIT in 1 CARTON (17478-701-02) * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, SINGLE-DOSE * 10 mL in 1 AMPULE

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength25MG/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:APRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength50MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength10MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Moodys
Mallinckrodt
McKinsey
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.